For the Inventor, By the Inventor

Enter assignee name

San Mateo, CA, United States of America

Maxygen, Inc.

USPTO Granted Patents = 124

CIPO Patents = 2

EPO Patents = 6

Trademarks = 1

Forward Citations = 16,499

Loading Chart...

Loading Chart...

116 inventors (with patents filed for the assignee):

Willem P C Stemmer (70 out of 90 patents)

Phillip A Patten (54 out of 100 patents)

Jeremy S Minshull (38 out of 123 patents)

4. Jon Edward Ness (20 out of 42 patents)

5. Claes Gustafsson (19 out of 44 patents)

6. Matthew B Tobin (16 out of 24 patents)

7. Steven Henry Bass (15 out of 30 patents)

8. Torben Lauesgaard Nissen (13 out of 19 patents)

9. Mark D Welch (13 out of 40 patents)

10. Andreas Crameri (12 out of 23 patents)

11. Sridhar Viswanathan (12 out of 13 patents)

12. Sridhar Govindarajan (11 out of 36 patents)

13. Linda A Castle (10 out of 39 patents)

14. Juha Punnonen (10 out of 30 patents)

15. Lorraine Joan Giver (8 out of 42 patents)

Core Competencies:

Antibody Diversity Generation

Cellular Engineering

Metabolic Engineering

Polypeptide Engineering

Functional Biomolecules

Directed Evolution

Immunomodulatory Properties

High Throughput Mass Spectrometry

Cytokine Polypeptides

Chimeric Promoters

Subtilisin Variants

G-CSF Conjugates

124 patents: Sort by Forward Citations

1. 8252727 - Antibody diversity generation (2012-08-28),

2. 7795030 - Methods and compositions for cellular and metabolic engineering (2010-09-14),

3. 7783428 - Methods, systems, and software for identifying functional biomolecules (2010-08-24),

4. 7776598 - Methods and compositions for polypeptide engineering (2010-08-17),

5. 7751986 - Methods, systems, and software for identifying functional biomolecules (2010-07-06),

6. 7747393 - Methods, systems, and software for identifying functional biomolecules (2010-06-29),

7. 7747391 - Methods, systems, and software for identifying functional biomolecules (2010-06-29),

8. 7702464 - Method and apparatus for codon determining (2010-04-20),

9. 7696153 - G-CSF conjugates (2010-04-13),

10. 7629170 - Evolution of whole cells and organisms by recursive sequence recombination (2009-12-08),

11. 7620502 - Methods for identifying sets of oligonucleotides for use in an in vitro recombination procedure (2009-11-17),

12. 7620500 - Optimization of crossover points for directed evolution (2009-11-17),

13. 7619067 - Evolved interferon-alpha polypeptides (2009-11-17),

14. 7612170 - Co-stimulatory polypeptides (2009-11-03),

15. 7605115 - Subtilisin variants (2009-10-20),

Maxygen, Inc. is a biotechnology company specializing in the development of protein drugs through molecular breeding technology. Their innovative approach utilizes directed evolution techniques to optimize protein characteristics, resulting in improved therapeutic outcomes. With a focus on creating novel treatments for a range of diseases, Maxygen aims to advance the field of biotechnology and improve patients' lives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

124 Patents

#12 in San Mateo, CA

#697 in California

#3,013 in US

#6,267 in the World

San Mateo, CA, United States of America

Maxygen, Inc.

Forward Citations = 16,499

116 inventors:

Willem P C Stemmer (70 out of 90 patents)

Phillip A Patten (54 out of 100 patents)

Jeremy S Minshull (38 out of 123 patents)

4. Jon Edward Ness (20 out of 42 patents)

5. Claes Gustafsson (19 out of 44 patents)

Please report any incorrect information to support@idiyas.com

Loading…